Related Experiment Video

Updated: Jun 21, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Stem cell therapy for end-stage heart failure: indispensable role for the cell?

K R Vrijsen1, S A J Chamuleau, W A Noort

  • 1Department of Cardiology, University Medical Centre Utrecht, The Netherlands. k.vrijsen@umcutrecht.nl

Current Opinion in Organ Transplantation
|July 23, 2009
PubMed

Insights

Cardiac cell therapy shows promise for heart failure, but its regenerative capacity is debated. Current evidence suggests that paracrine effects, not direct cell regeneration, may drive therapeutic benefits by activating resident stem cells.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Heart transplantation is limited by donor organ scarcity, driving research into alternative therapies like cell transplantation for heart failure.
  • Cellular therapies offer a potential solution, but challenges remain regarding delivery, cell survival, and in vivo function.

Purpose of the Study:

  • To review the potential of various stem cell types for cardiac regeneration in heart failure.
  • To investigate the mechanisms underlying the success of cell transplantation in cardiac repair.

Main Methods:

  • Review of preclinical studies on stem and progenitor cells for cardiac cell therapy.
  • Analysis of mechanisms contributing to observed beneficial effects in cardiac regeneration.

Main Results:

  • Mixed outcomes reported for different stem cell types in preclinical cardiac studies.
  • Limited engraftment and proliferation of transplanted cells challenge direct regeneration theories.
  • Paracrine effects are increasingly suggested as the primary mechanism for therapeutic benefits in cardiac cell therapy.

Conclusions:

  • Current stem cell therapies for heart failure may rely on paracrine signaling rather than direct myocardial regeneration.
  • These paracrine effects appear to mobilize and activate endogenous resident stem cells.
  • The findings challenge the classical understanding of cell therapy's regenerative capacity in the heart.
Abstract

More Related Videos

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...